Kaya Holdings, Inc. (OTC: KAYS)

Kaya Holdings, Inc. operates in the wellness and mental health sector, focusing on psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company has a diverse portfolio that includes operations in both the United States and internationally, particularly in Greece. Kaya Holdings has been a pioneer in the cannabis industry, becoming the first US public company to own and operate a medical cannabis dispensary. More recently, it has expanded into the psychedelic treatment space, opening The Sacred Mushroom Psychedelic Treatment Center in Portland, Oregon.

Kaya Holdings generates revenue through its various subsidiaries and brands, which offer a range of products and services. In the cannabis sector, the company produces and sells premium cannabis products, including flower, oils, vape cartridges, and cannabis-infused confections, baked goods, and beverages. The company's brands include Kaya Farms and Kaya Buddie. In the psychedelic treatment sector, Kaya Holdings operates The Sacred Mushroom, a facility that provides psychedelic "mind care" treatments to individuals suffering from various mental health disorders. The company also has international operations, with licenses for medical marijuana production and processing in Greece.

• Psychedelic Treatment Clinics: Kaya Holdings operates The Sacred Mushroom Psychedelic Treatment Center in Portland, Oregon, which offers psychedelic treatments to individuals with treatment-resistant mental health disorders. The facility provides a safe and controlled environment for clients to undergo psilocybin treatments under the supervision of state-licensed facilitators. The Sacred Mushroom is part of the company's Fifth Dimension Therapeutics subsidiary, which aims to maximize the curative and therapeutic potential of psilocybin.

• Medical and Recreational Cannabis: Kaya Holdings has a long-standing presence in the cannabis industry, with operations spanning cultivation, manufacturing, and retail. The company produces a full range of premium cannabis products, including flower, oils, vape cartridges, and cannabis-infused edibles and beverages. Kaya Holdings operates under various brands, such as Kaya Farms and Kaya Buddie, and has a extensive genetic library of cannabis seeds.

• CBD Products: While not explicitly detailed in the filing, Kaya Holdings' involvement in the wellness sector suggests that the company may also generate revenue from CBD products, which are derived from cannabis but contain little to no THC, the psychoactive compound found in cannabis.

• International Operations: Kaya Holdings has expanded its operations internationally, with a focus on Greece. The company has acquired licenses for medical marijuana production and processing in Greece and plans to cultivate and manufacture cannabis products for distribution in the Greek, German, and other EU markets.

Kaya Holdings operates in a competitive industry, facing significant competition from both established and emerging players in the cannabis and psychedelic treatment sectors. Key competitors include companies such as Compass Pathways, ATAI Life Sciences, and Cybin, which are developing synthetic versions of psilocybin for therapeutic use. In the cannabis sector, the company competes with well-established firms that have greater financial resources, industry contacts, and experience. Despite the competitive landscape, Kaya Holdings has several competitive advantages. The company has a decade of operational experience in the cannabis industry, giving it a strong foundation in cultivation, manufacturing, and retail. Additionally, its early entry into the psychedelic treatment space and its existing infrastructure in Oregon provide a strategic advantage. The company's international operations in Greece also position it to tap into the growing European cannabis market.

The customer base for Kaya Holdings is diverse, encompassing individuals seeking mental health treatments, medical cannabis patients, and recreational cannabis users. The Sacred Mushroom Psychedelic Treatment Center caters to individuals with treatment-resistant mental health disorders, including veterans suffering from PTSD, addicts seeking to break addiction, and individuals with eating disorders. The company's cannabis products are targeted at both medical and recreational users, with a focus on premium quality. In the international market, Kaya Holdings aims to serve the medical cannabis market in Greece and other EU countries, subject to local regulations. The company's ability to cater to a broad range of customers across different sectors positions it well for growth in the evolving wellness and mental health landscape.